# Substantial Equivalence of iSlpr™ and SomnoDent® Classic in the Treatment of Snoring and Mild to Moderate Sleep Apnoea.

> **NCT04250584** · NA · UNKNOWN · sponsor: **BioAnalytics Holdings Pty Ltd** · enrollment: 66 (estimated)

## Conditions studied

- Sleep Apnea
- Snoring

## Interventions

- **DEVICE:** iSlpr™
- **DEVICE:** SomnoDent® Classic

## Key facts

- **NCT ID:** NCT04250584
- **Lead sponsor:** BioAnalytics Holdings Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03
- **Primary completion:** 2021-06
- **Final completion:** 2021-06
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2020-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04250584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04250584, "Substantial Equivalence of iSlpr™ and SomnoDent® Classic in the Treatment of Snoring and Mild to Moderate Sleep Apnoea.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04250584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*